Barbara Pantuso, director of healthcare innovation at frog design, reports on health outcomes and financial implications of Evidence-Based Design (EBD).
“It’s similar to how healthcare professionals make treatment decisions and how insurance companies determine coverage. They are heavily influenced by patient outcomes. If there is systematic evidence of statistically significant improved outcomes, then doctors will more likely prescribe certain treatment regimens (medication, lifestyle, devices, etc) and insurance companies or the government will more likely cover the costs. This is called evidenced-based medicine or evidenced-based treatment.”